equityflowunderstand the flow and follow it
EquityFlow › Companies › Semarion

Semarion

Biotech · Cambridge, GB

University of Cambridge spin-out converting adherent cells into barcoded, assay-ready microcarriers (SemaCyte) for drug discovery.

In the network

Shares the most investors with (number = shared investors):
Wave Photonics 2xWatts 2

Members see the full profile

Create a free EquityFlow account to see Semarion's 1 funding round, 7 investors, 12 similar companies.

Sign up free → Sign in